TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

VERONA PHARMA

RespiratoryInfectious Disease
Pharma

VERONA PHARMA is a pharmaceutical company focused on Respiratory, Infectious Disease. Key products include OHTUVAYRE.

2024
Since
1
Drugs
-
Trials
1
Approved (2yr)

Key Drugs

OHTUVAYRE
ensifentrine
Respiratory
PDE3 1 indications · 2024

Recent Activity

OHTUVAYRE 2024-06-26
Type 1 - New Molecular Entity
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Respiratory 96%
1 drugs Phase 3: 3 Phase 2: 14
Infectious Disease 4%
0 drugs Phase 2: 1

Pipeline Strength Pro

Loading...

Competitors Pro

GSK big-pharma
Infectious Disease, Respiratory
Sanofi big-pharma
Infectious Disease, Respiratory
GE HEALTHCARE specialty
Infectious Disease, Respiratory
APOTHECON specialty
Infectious Disease, Respiratory
PHARMACIA AND UPJOHN big-pharma
Infectious Disease, Respiratory